The West Bengal School Service Commission (WBSSC) has announced the initial interview list for the State Level Selection Test ...
Premier Graphene remains committed to meeting the evolving needs of the defense and technology sectors and private industry, ...
ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic ...
This completion is a crucial requirement in the approval process for a drug.
Premier Graphene, Inc. (OTC: BIEI), a developer of advanced graphene-based defense and protective-wear fortification technologies, reports consistently ...
Scattered across a couple tables at Montana Fish, Wildlife and Parks Region 3 Headquarters on Wednesday night, were the ...
Alixorexton, an investigational, oral, selective orexin 2 receptor agonist, demonstrated meaningful improvements across the trial’s dual primary endpoints of change from baseline in Maintenance of ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Alkermes reports positive results from Vibrance-2 phase 2 study of once-daily alixorexton in patients with narcolepsy type 2: Dublin Friday, November 14, 2025, 18:00 Hrs [IST] Alk ...
AIRJ Expands Strategic Partnerships and Advances Productization of AirJoule™ Systems Ahead of Commercial Deployments in 2026 ...
No monitoring and measurement effort will be more important to the long-term health of communities than understanding and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback